Media Forum Articles

How do CPG alliances aid pharmas?

April 15, 2011

Teva's alliance with P&G should enable the drugmaker to get competitive rates on global media buys for its OTC products. Are there other opportunities for firms to gain media-buying scale by partnering with CPG advertisers?
 

Does new policy hurt transparency?

March 15, 2011

The FDA decided to bar reporters from consulting outside experts about embargoed news. Journalists say this runs counter to FDA's pledge to increase transparency. The agency says otherwise. Is this sound policy?
 

Should journals expand disclosure?

February 14, 2011

In the wake of the insider-trading probe involving Human Genome Sciences, should journals expand disclosure rules for researchers to include ties to the financial community? Due diligence or transparency overkill?
 

Will pharmas keep shifting duties?

January 14, 2011

GlaxoSmithKline's decision in late 2010 to shift consumer media-planning and -buying duties for all its brands was a fresh signal that no media account is beyond review. Will we see more pharma clients rock the boat this year?
 

Will journals take online dollars?

December 15, 2010

Revenge of the dead trees? If journals begin 2011 like they started off 2010, with an infusion of pharma ad dollars, will their revival draw advertising spend away from professional online promotion?
 

Will specialty titles start growing?

November 15, 2010

Publishers of multispecialty and primary care titles enjoyed the largest ad-spend gains in a resurgent first-half 2010. Will things get more interesting for the specialty care segment, as well?
 

Will journal ad recovery last long?

October 15, 2010

Journal ad revenues took an unforeseen turn for the better in the first half of the year, with overall ad spend jumping 14.3% from January to June. What's behind the upsurge and will it continue?
 

Is Grassley's ghostwriting report still relevant?

September 15, 2010

Sen. Chuck Grassley released a report shedding light on the controversial practice of ghostwriting. Some say his findings are based on outdated publication-planning practices. How should we put Sen. Grassley's report in context?
 

Where is professional media headed?

August 16, 2010

With journal spend taking a dive, many agencies have jettisoned internal media buyers, outsourcing to the big network shops among others. What do you see as the potential for employment and career advancement?
 

How can mobile improve access?

July 15, 2010

Millions of patients across the country are set to enter the healthcare system, each with different insurance plans and tolerance for drug co-pays. How are you using mobile technology and social media to improve access?
 
« Previous
Next »

Video Exclusive

Web Exclusives

Five industry experts advise specialty pharma company on digital strategy

April 20, 2012

Specialty pharma company POZEN assembled a crack team of experts to help shape its digital strategy. Not only did POZEN share with us the text from their contributions, but you can watch exclusive video clips of their valuable perspectives right here.
 

MM&M Awards 2011 HIghlights

The Best MM&M Awards Ever!

MAHF Ceremony 2012

Photos from the Medical Advertising Hall of Fame Awards ceremony
 
Popular Topics
Acquisition Adherence App Celebrity Clinical Trial Co-Marketing Diabetes Diagnostics Digital Direct To Consumer (DTC) Disease Awareness Downsize Education & Awareness FDA Government Guidance Health Plans HMOs Hospitals Insurers Law Marketing Research Medical Journal Mobile Sales Force